193 related articles for article (PubMed ID: 33325655)
1. Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.
Hung SP; Chen PR; Ho TY; Chang KP; Chou WC; Lee CH; Wu YY; Chen PJ; Lin CH; Chou YC; Fan KH; Lin CY; Huang BS; Tung-Chieh Chang J; Wang CC; Tsang NM
Cancer Med; 2021 Jan; 10(2):649-658. PubMed ID: 33325655
[TBL] [Abstract][Full Text] [Related]
2. Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection.
Diao P; Wu Y; Li J; Zhang W; Huang R; Zhou C; Wang Y; Cheng J
J Transl Med; 2018 Dec; 16(1):365. PubMed ID: 30563540
[TBL] [Abstract][Full Text] [Related]
3. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.
Obata Y; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Surg Today; 2023 Aug; 53(8):964-972. PubMed ID: 36797438
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
[TBL] [Abstract][Full Text] [Related]
5. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
[TBL] [Abstract][Full Text] [Related]
6. Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy.
Wu YY; Chang KP; Ho TY; Chou WC; Hung SP; Fan KH; Chiang YY; Chou YC; Tsang NM
Cancer Med; 2021 Mar; 10(6):1975-1988. PubMed ID: 33624454
[TBL] [Abstract][Full Text] [Related]
7. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
9. Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Yang J; Zheng J; Qiu J; Zhang M; Liu L; Wang Z; Zheng Q; Liu Y; Chen M; Li J
J Immunol Res; 2023; 2023():4275998. PubMed ID: 37228442
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
12. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
[No Abstract] [Full Text] [Related]
13. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
14. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.
Wang L; Wang C; Wang J; Huang X; Cheng Y
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935
[TBL] [Abstract][Full Text] [Related]
15. Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
Kang CJ; Lin CY; Yang LY; Ho TY; Lee LY; Fan KH; Wang HM; Huang SF; Chang KP; Fang KH; Ng SH; Liao CT; Yen TC
J Nucl Med; 2015 Jan; 56(1):22-30. PubMed ID: 25525186
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.
Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P
J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
20. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
Topkan E; Besen AA; Ozdemir Y; Kucuk A; Mertsoylu H; Pehlivan B; Selek U
Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]